U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06866600) titled 'IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure' on March 04.
Brief Summary: This clinical trial investigates the safety, feasibility, and therapeutic potential of a combined approach using HiCM-188 cardiomyocyte injection delivered intramyocardially alongside either LVAD implantation or CABG surgery in patients with advanced ischemic heart failure.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Heart Failure
Heart Failure At NYHA Stage III or IV
Intervention:
BIOLOGICAL: low dose CABG+iPSC-CMs
CABG+0.5x10^8 iPSC-CMs
BIOLOGICAL: High dose CABG/LVAD+iPSC-CMs
CABG+1.5x10^8 iPSC-CMs...